Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

5 Ultra-High Dividend Stocks Hedge Funds Are Betting On

Page 1 of 2

With the rate hike from the Fed still far from a reality, there aren’t a lot of satisfactory fixed-income opportunities for retail investors out there. Investing in dividend stocks can be tricky too, as the companies offering extremely high yields come with greater risks, which could result in a cratering stock price, or those yields being dramatically slashed, or a combination of both. In order to minimize this risk we decided to look at the high-yield companies, which have earned the trust of more hedge funds that we track than other similar stocks. We have organized the list by their popularity among the professional money managers we track.


Why do we pay attention to hedge fund sentiment? Most investors ignore hedge funds’ moves because as a group their average net returns trailed the market since 2008 by a large margin. Unfortunately, most investors don’t realize that hedge funds are hedged and they also charge an arm and a leg, so they are likely to underperform the market in a bull market. We ignore their short positions and by imitating hedge funds’ stock picks independently, we don’t have to pay them a dime. Our research have shown that hedge funds’ long stock picks generate strong risk adjusted returns. For instance the 15 most popular small-cap stocks outperformed the S&P 500 Index by an average of 95 basis points per month in our back-tests spanning the 1999-2012 period. We have been tracking the performance of these stocks in real-time since the end of August 2012. After all, things change and we need to verify that back-test results aren’t just a statistical fluke. We weren’t proven wrong. These 15 stocks managed to return 118% over the last 35 months and outperformed the S&P 500 Index by 60.4 percentage points (see the details here).

5. Vale SA (ADR) (NYSE:VALE)

Investors with Long Positions (as of June 30): 22

Aggregate Value of Investors’ Holdings (as of June 30): $303.46 Million

Although the total number of funds with investments in Vale SA (ADR) (NYSE:VALE) decreased slightly from 23 at the end of March, the total investments surged from $242.56 million. The stock price rose by a little over 11% during this period as compared to the 25% increase in investment. Vale SA (ADR) (NYSE:VALE) decreased its semi-annual dividend to about $0.19, less than half of what it paid out in 2014. Nonetheless, the dividend yield of the stock has soared to 7.91% as shares of the company have crumbled, losing 63.76% over the past year. Richard Gerson and Navroz D. Udwadia’s Falcon Edge Capital is the largest stockholder of Vale SA (ADR) (NYSE:VALE) within our database, holding some 17.48 million shares.

4. Banco Santander, S.A. (ADR) (NYSE:SAN)

Investors with Long Positions (as of June 30): 23

Aggregate Value of Investors’ Holdings (as of June 30): $153.74 Million

The $87.73 billion Spain-based bank holding company offers a dividend yield of 3.53%. Banco Santander also slashed its dividend recently, by slightly over $0.11 quarterly, as its own stock has sank by over 36% in the past year. At the end of the first quarter only 16 funds had a total investment of $153.74 million in Banco Santander, S.A. (ADR) (NYSE:SAN).  John W. Rogers‘ Ariel Investments and Howard Marks‘ Oaktree Capital Management are two prominent funds that were bullish on Banco Santander, S.A. (ADR) (NYSE:SAN) during the June quarter, raising their respective holdings by 8% and 116% to 1.06 million shares and 882,800 shares respectively.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!